Share This Article:

Current State of Nanoemulsions in Drug Delivery

Full-Text HTML Download Download as PDF (Size:236KB) PP. 626-639
DOI: 10.4236/jbnb.2011.225075    15,139 Downloads   29,984 Views   Citations


Nanoemulsions have attracted great attention in research, dosage form design and pharmacotherapy. This is as a result of a number of attributes peculiar to nanoemulsions such as optical clarity, ease of preparation, thermodynamic stability and increased surface area. Nanoemulsions also known as submicron emulsions serve as vehicles for the delivery of active pharmaceutical ingredients as well as other bioactives. They are designed to address some of the problems associated with conventional drug delivery systems such as low bioavailability and noncompliance. The importance of design and development of emulsion nanocarrier systems aimed at controlling and/or improving required bioavailability levels of therapeutic agents cannot be overemphasized. Reducing droplet sizes to the nanoscale leads to some very interesting physical properties, such as optical transparency and unusual elastic behaviour. This review sheds light on the current state of nanoemulsions in the delivery of drugs and other bioactives. The morphology, formulation, characteristics and characterization of nanoemulsions were also addressed.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Lovelyn, C. and Attama, A. (2011) Current State of Nanoemulsions in Drug Delivery. Journal of Biomaterials and Nanobiotechnology, 2, 626-639. doi: 10.4236/jbnb.2011.225075.


[1] P. Shah, D. Bhalodia and P. Shelat, “Nanoemulsion: A Pharmaceutical Review,” Systematic Reviews in Pharmacy, Vol. 1, No. 1, 2010, pp. 24-32. doi:10.4103/0975-8453.59509
[2] T. P. U. Ravi and T. Padma, “Nanoemulsions for Drug Delivery through Different Routes,” Research in Biotechnology, Vol. 2, No. 3, 2011, pp. 1-13.
[3] N. Anton and T. Vandamme, “The Universality of Low- Energy Nano-Emulsification,” International Journal Pharmaceutics, Vol. 377, No. 1-2, 2009, pp. 142-147. doi:10.1016/j.ijpharm.2009.05.014
[4] T. G. Mason, S. M. Graves, J. N. Wilking and M. Y. Lin, “Extreme Emulsification: Formation and Structure of Nanoemulsions,” Journal of Physics and Condensed Matter, Vol. 9, No. 1, 2006, pp. 193-199.
[5] S. Graves, K. Meleson and J. Wilking, “Structure of Concentrated Nanoemulsions,” Journal of Chemical Physics, Vol. 122, No. 13, 2005, Article ID 134703. doi:10.1063/1.1874952
[6] S. M. Jafari, Y. He and B. Bhandari, “Optimization of Nanoemulsion Production by Microfluidization,” European Food Research Technology, Vol. 225, No. 5-6, 2007, pp. 733-741. doi:10.1007/s00217-006-0476-9
[7] C. Quin and D. J. Mc Clement, “Formation of Nano- emulsions Stabilized by Model Food Grade Emulsifiers Using High Pressure Homogenization: Factors Effecting Particle Size,” Food Hydrocolloids, Vol. 25, No. 5, 2011, pp. 1000-1008. doi:10.1016/j.foodhyd.2010.09.017
[8] O. Sonneville-Aubrun, J. T. Simonnet and F. L’Alloret, “Nanoemulsions: A New Vehicle for Skincare Products,” Advances in Colloids and Interface Science, Vol. 108-109, 2004, pp. 145-149. doi:10.1016/j.cis.2003.10.026
[9] C. Solans, P. Izquierdo, J. Nolla, N. Azemar and M. J. Garcia-Celma, “Nano-Emulsions,” Current Opinion in Colloid and Interface Science, Vol. 10, No. 3-4, 2005, pp. 102-110. doi:10.1016/j.cocis.2005.06.004
[10] L. Wang, X. Li, G. Zhang, J. Dong and J. Eastoe, “Oil-in-Water Nanoemulsions for Pesticide Formulations,” Journal of Colloid and Interface Science, Vol. 314, No. 1, 2007, pp. 230-235. doi:10.1016/j.jcis.2007.04.079
[11] I. Sole, A. Maestro, C. M. Pey, C. Gonzalez, C. Solans and J. M. Gutierrez, “Nanoemulsions Preparation by Low Energy Methods in an Ionic Surfactant System,” Colloids and Surfaces A: Physiochemical Engineering Aspects, Vol. 288, 2006, pp. 138-143.
[12] I. Sole I, C. M. Pey, A. Maestro, C. Gonzalez, M. Porras, C. Solans and J. M. Gutierrez, “Nanoemulsions Prepared by Phase Inversion Composition Method: Preparation Variables and Scale up,” Journal of Colloid and Interface Science, Vol. 344, No. 2, 2010, pp. 417-423. doi:10.1016/j.jcis.2009.11.046
[13] T. Tadros, P. Izquierdo, J. Esquena and C. Solans, “Formation and Stability of Nanoemulsions,” Advances in Colloids and Interface Science, Vol. 108-109, 2004, pp. 303-318. doi:10.1016/j.cis.2003.10.023
[14] R. Aboofazeli, “Nanometric Scaled Emulsions (Nano- emulsions),” Iranian Journal of Pharmaceutical Research, Vol. 9, No. 4, 2010, pp. 325-326.
[15] A. Pires A, A. Fortuna, G. Alves and A. Falcao, “Intranasal Drug Delivery: How, Why and What for,” Journal of Pharmacy and Pharmaceutical Sciences, Vol. 12, 2009, pp. 288-311.
[16] M. I. Ugwoke, R. U. Agu, N. Verbeke and R. Kinget, “Nasal Mucoadhesive Drug Delivery: Background, Applications, Trends, and Future Perspectives,” Advanced Drug Delivery Reviews, Vol. 57, No. 11, 2005, pp. 1640-1665. doi:10.1016/j.addr.2005.07.009
[17] W. M. Pardridge, “Non-Invasive Drug Delivery to Human Brain Using Endogenous Blood Brain Barrier Transport System,” Pharmaceutical Science and Technology Today, Vol. 2, No. 2, 1999, pp. 49-59. doi:10.1016/S1461-5347(98)00117-5
[18] M. Kumar, A. Misra, A. K. Babbar and A. K. Mishra, “Intranasal Nanoemulsion Based Brain Targeting Drug Delivery System of Risperidone,” International Journal of Pharmaceutics, Vol. 358, 1-2, 2008, pp. 285-291. doi:10.1016/j.ijpharm.2008.03.029
[19] A. Mistry A, S. Stolnik and L. Illum, “Nanoparticles for Direct Nose-To-Brain Delivery of Drugs,” International Journal of Pharmaceutics, Vol. 379, No. 1, 2009, pp. 146-157. doi:10.1016/j.ijpharm.2009.06.019
[20] N. Csaba, M. Garcia-Fuentes and M. J. Alonsa, “Nanoparticles for Nasal Vaccination,” Advanced Drug Delivery Reviews, Vol. 61, No. 2, 2009, pp. 140-157. doi:10.1016/j.addr.2008.09.005
[21] A. M. Clark, M. A. Jepson and B. H. Hirst, “Exploiting M Cells for Drug and Vaccine Delivery,” Advanced Drug Delivery Reviews, Vol. 50, No. 1-2, 2001, pp. 81-106. doi:10.1016/S0169-409X(01)00149-1
[22] C. C. Muller-Goymann, “Physicochemical Characterization of Colloidal Drug Delivery Systems such as Reverse Micelles, Vesicles, Liquid Crystals and Nanoparticles for Topical Administration,” European Journal of Pharmaceutics and Biopharmaceutics, Vol. 58, No. 2, 2004, pp. 343-356. doi:10.1016/j.ejpb.2004.03.028
[23] P. K. Gaur, S. Mishra, S. Purohit and K. Dave, “Transdermal Drug Delivery System: A Review,” Asian Journal of Pharmaceutical and Clinical Research, Vol. 2, No. 1, 2009, pp. 14-20.
[24] F. Shakee and W. Ramadan, “Transdermal Delivery of Anticancer Drug Caffeine from Water-in-Oil Nanoemulsions,” Colloids and Surfaces B: Biointerfaces, Vol. 75, No. 1, 2010, pp. 356-362. doi:10.1016/j.colsurfb.2009.09.010
[25] D. W. Osborne, A. J. Ward and K. J. Neil, “Microemulsions as Topical Delivery Vehicles: In-Vitro Transdermal Studies of a Model Hydrophilic Drug,” Journal of Pharmacy and Pharmacology, Vol. 43, No. 6, 1991, pp. 450- 454. doi:10.1111/j.2042-7158.1991.tb03511.x
[26] M. Trotta, F. Pattarino and M. R. Gasco, “Influence of Counter Ions on the Skin Permeation of Methotrexate from Water-Oil Microemulsions,” Pharmaceutia Acta Helvetiae, Vol. 71, No. 2, 1996, pp. 135-140. doi:10.1016/0031-6865(96)00003-9
[27] M. B. Delgado-Charro, G. Iglesias-Vilas, J. Blanco- Mendez, M. J. Lopez-Quintela, M. A. Marty and J. P. Guy, “Delivery of a Hydrophilic Solute through the Skin from Novel Microemulsion Systems,” European Journal of Pharmaceutics and Biopharmaceutics, Vol. 43, No. 1, 1997, pp. 37-42. doi:10.1016/S0939-6411(96)00016-1
[28] F. Dreher, P. Walde, P. Walter and E. Wehrli, “Interaction of a Lecithin Microemulsion Gel with Human Stratum Corneum and Its Effect on Transdermal Transport,” Journal of Controlled Release, Vol. 45, No. 2, 1997, pp. 131-140. doi:10.1016/S0168-3659(96)01559-3
[29] U. Schmalfus, R. Neubart and W. Wohlrab, “Modification of Drug Penetration into Human Skin Using Microemulsions,” Journal of Controlled Release, Vol. 46, No. 3, 1997, pp. 279-285. doi:10.1016/S0168-3659(96)01609-4
[30] M. Kreilgaard, E. J. Pedersen and J. W. Jaroszewski, “NMR Characterization and Transdermal Drug Delivery Potentials of Microemulsion Systems,” Journal of Controlled Release, Vol. 69, No. 3, 2000, pp. 421-433. doi:10.1016/S0168-3659(00)00325-4
[31] M. J. Alvarez-Figueroa and J. Blanco-Mendez, “Transdermal Delivery of Methotrexate: Iontophoretic Delivery from Hydrogels and Passive Delivery from Microemulsions,” International Journal of Pharmaceutics, Vol. 215, No. 1-2, 2001, pp. 57-65.
[32] Y. S. Rhee, J. G. Choi, E. S. Park and S. C. Chi, “Transdermal Delivery of Ketoprofen Using Microemulsions,” International Journal of Pharmaceutics, Vol. 228, No. 1, 2001, pp. 161-170.
[33] P. J. Lee, R. Langer and V. P. Shastri, “Novel Microemulsion Enhancer Formulation for Simultaneous Transdermal Delivery of Hydrophilic and Hydrophobic Drugs,” Pharmaceutical Research, Vol. 20, No. 2, 2003, pp. 264-269. doi:10.1023/A:1022283423116
[34] J. Kemken, A. Ziegler and B. W. Muller, “Influence of Supersaturation on the Pharmacodynamic Effect of Bupranolol after Dermal Administration Using Microemulsions as Vehicle,” Pharmaceutical Research, Vol. 9, No. 4, 1992, pp. 554-558. doi:10.1023/A:1015856800653
[35] M. Kreilgaard, “Dermal Pharmacokinetics of Microemulsion Formulations Determined by In-Vitro Microdialysis,” Pharmaceutical Research, Vol. 18, No. 3, 2001, pp. 367-373. doi:10.1023/A:1011067300397
[36] M. Kreilgaard, M. J. B. Kemme, J. Burggraaf, R. C. Schoemaker and A. F. Cohen, “Influence of a Microemulsion Vehicle on Cutaneous Bioequivalence of a Lipophilic Model Drug Assessed by Microdialysis and Pharmacodynamics,” Pharmaceutical Research, Vol. 18, No. 5, 2001, pp. 593-599. doi:10.1023/A:1011068907416
[37] G. Ktistis and I. Niopas I, “A Study on the In-Vitro Percutaneous Absorption of Propranolol from Disperse Systems,” Journal of Pharmacy and Pharmacology, Vol. 50, 1998, pp. 413-419. doi:10.1111/j.2042-7158.1998.tb06881.x
[38] M. R. Gasco and M. Gallarate and F. Pattarino, “In Vitro Permeation of Azelaic Acid from Viscosized Microemulsions,” International Journal of Pharmaceutics, Vol. 69. 1999, pp. 193-196.
[39] K. Kriwet and C. C. Muller-Goymann, “Diclofenac release from Phospholipid Drug Systems and Permeation through Excised Human Stratum Corneum,” International Journal of Pharmaceutics, Vol. 125, No. 2, 1995, pp. 231-242. doi:10.1016/0378-5173(95)00130-B
[40] M. Trotta, “Influence of Phase Transformation on Indomethacin Release from Microemulsions,” Journal of Controlled Release, Vol. 60, No. 2, 1999, pp. 399-405. doi:10.1016/S0168-3659(99)00094-2
[41] R. Patel and K. P. Patel, “Advances in Novel Parenteral Drug Delivery Systems,” Asian Journal of Pharmaceutics, Vol. 4, 3, 2010, pp. 193-199. doi:10.4103/0973-8398.72117
[42] F. A. Araujo, R. G. Kelmann, B. V. Araujo, R. B. Finatto, H. F. Teixeira and L. S. Koester, “Development and Characterization of Parenteral Nanoemulsions Containing Thalidomide,” European Journal of Pharmaceutical Science, Vol. 42, No. 5, 2011, pp. 238-245. doi:10.1016/j.ejps.2010.11.014
[43] S. Ganta, D. Deshpande, A. Korde and M. Amiji, “A Review of Multifunctional Nanoemulsion Systems to Overcome Oral and CNS Drug Delivery Barriers,” Molecules and Membrane Bioliology, Vol. 27, No. 7, 2010, pp. 260-273. doi:10.3109/09687688.2010.497971
[44] R. G. Kelmann, G. Kuminek, H. Teixeira and L. S. Koester, “Carbamazepine parenteral Nanoemulsions Prepared by Spontaneous Emulsification Process,” International Journal of Pharmaceutics, Vol. 342, No. 1-2, 2007, pp. 231-239. doi:10.1016/j.ijpharm.2007.05.004
[45] F. L. Primo, L. Michieloto, M. A. M. Rodrigues, P. P. Macaroff, P. C. Morais, Z. G. M. Lacava, M. V. L. B. Bently and A. C. Tedesco, “Magnetic Nanoemulsions as Drug Delivery System for Foscan: Skin Permeation and Retention in Vitro Assays for Topical Application in Photodynamic Therapy (PDT) of Skin Cancer,” Journal of Magnetism and Magnetic Materials, Vol. 311, No. 1, 2007, pp. 354-357. doi:10.1016/j.jmmm.2006.10.1183
[46] A. Bielinska, K. Janxzak and J. Landers, “Nasal Immunization with a Recombinant HIV gp120 and Nanoemulsion Adjuvant Produces Thl polarized Responses and NEUTRALIZING Antibodies to Primary HIV Type Isolates,” AIDS Research and Human Retroviruses, Vol. 24, No. 2, 2008, pp. 271-281. doi:10.1089/aid.2007.0148
[47] A. C. Berkowltz and D. M. Goddard, “Novel Drug Delivery Systems: Future Directions,” Pharmacology Update, April 2009.
[48] H. M. Mansour, Y. S. Rhee, W. Xiao, “Nanomedicine in Pulmonary Delivery,” International Journal of Nano- medicine, Vol. 4, 2009, pp. 299-319. doi:10.2147/IJN.S4937
[49] F. Liu, J. Yang, L. Huang and D. Liu, “Effect of Non-Ionic Surfactants on the Formation of DNA/Emulsion Complexes and Emulsion-Mediated Gene Transfer,” Pharmaceutical Research, Vol. 13, No. 11, 1996, pp. 1642-1646. doi:10.1023/A:1016480421204
[50] S. W. Yi, T. Y. Yune, T. W. Kim, H. Chung, et al., ”A Cationic Lipid Emulsion/DNA Complex as a Physically Stable and Serum-Resistant Gene Delivery System,” Pharmaceutical Research, Vol. 17, No. 3, 2000, pp. 314-320. doi:10.1023/A:1007553106681
[51] C.-H. Liu and S.-Y. Yu, “Cationic Nanoemulsions as Non-Viral Vectors for Plasmid DNA Delivery,” Colloids and Surfaces B: Biointerfaces, Vol. 79, No. 2, 2010, pp. 509-515. doi:10.1016/j.colsurfb.2010.05.026
[52] M. Bivas-Benita, M. Oudshoorn, S. Romeijn, et al., “Cationic Submicron Emulsions for Pulmonary DNA Immunization,” Journal of Control Release, Vol. 100, No. 1, 2004, pp. 145-155. doi:10.1016/j.jconrel.2004.08.008
[54] J. B. Kayes, “Disperse Systems,” In: M. E. Aulton, Ed., Pharmaceutics the Science of Dosage Form Design, 1st Edition, Churchill Livingstone, Edinburgh, 1999, pp. 81-118, 571.
[55] M. J. Barea, M. J. Jekins, M. H. Gaber, et al., “Evaluation of Liposomes Coated with a pH Responsive Polymer,” International Journal of Pharmaceutics, Vol. 402, No. 1, 2010, pp. 89-94.
[56] N. A, Samah, N. Williams and C. M. Heard, “Nanogel Particulates Located within Diffusion Cell Receptor Phases Following Topical Application Demonstrates Uptake into and Migration Across Skin,” International Journal of Pharmaceutics, Vol. 401, No. 1-2, 2010, pp. 72-78. doi:10.1016/j.ijpharm.2010.08.011
[57] H. S. Ruth, D. Attwood, G. Ktistis and C. Taylor, “Phase Studies and Particle Size Analysis of Oil-in-Water Phospholipid Microemulsions,” International Journal of Pharmaceutics, Vol. 116, No. 2, 1995, pp. 253-261. doi:10.1016/0378-5173(94)00316-W
[58] X. Li, N. Anton, T. M. C. Ta, M. Zhao, N. Messaddeq and T. F. Vandamme, “Microencapsulation of Nano-emulsions: Novel Trojan Particles for Bioactive Lipid Molecule Delivery,” International Journal of Nanomedicine, Vol. 2011, No. 6, 2011, pp. 1313-1325.
[59] Y. Agrawal, K. C. Petkar and K. K. Sawant, “Development, Evaluation and Clinical Studies of Acitretin Loaded Nanostructured Lipid Carriers for Topical Treatment of Psoriasis,” International Journal of Pharmaceutics, Vol. 401, No. 1-2, 2010, pp. 93-102. doi:10.1016/j.ijpharm.2010.09.007
[60] E. Touitou, N. Dayan, L. Bergelson, et al., “Ethosomes— Novel Vesicular Carriers for Enhanced Delivery: Characterization and Skin Penetration Properties,” Journal of Controlled Release, Vol. 65, No. 3, 2000, pp. 403-418. doi:10.1016/S0168-3659(99)00222-9
[61] E. R. Bendas and M. I. Tadros, “Enhanced Transdermal Delivery of Salbutamol Sulfate via Ethosomes,” AAPS PharmSciTech, Vol. 8, No. 4, 2007, pp. 214-220.
[62] S. Jain, A. K. Tiwary, B. Sapra, et al., “Formulation and Evaluation of Ethosomes for Transdermal Delivery of Lamivudine,” AAPS PharmSciTech, Vol. 8, No. 4, 2007, pp. 249-257. doi:10.1208/pt0804111
[63] V. Dave, D. Kumar, S. Lewis, et al., “Ethosome for Enhanced Transdermal Drug Delivery of Aceclofenac,” International Journal of Drug Delivery, Vol. 2, 2010, pp. 81-92. doi:10.5138/ijdd.2010.0975.0215.02016
[64] S. Shafiq, S. Faiyaz, T. Sushma, F. J. Ahmad, R. K. Khar and M. Ali, “Development and Bioavailability Assessment of Ramipril Nanoemulsion Formulation,” European Journal of Pharmaceutics and Biopharmaceutics, Vol. 66, No. 2, 2007, pp. 227-243. doi:10.1016/j.ejpb.2006.10.014
[65] S. Amselem and D. Friedman, “Submicron Emulsions as Drug Carriers for Topical Administration,” In: S. Benita, Ed., Submicron Emulsions in Drug Targeting and Delivery, The Netherlands, Harwood Academic Publishers, Amsterdam, 1998, pp. 153-173.
[66] F. Shakeel, S. Baboota, A. Ahuja, J. Ali, M. Aqil and S. Shafiq, “Nanoemulsions as Vehicles for Transdermal Delivery of Aceclofenac,” AAPS PharmSciTech, Vol. 8, No. 4, 2007, pp. 191-199. doi:10.1208/pt0804104
[67] K. G. Pradip, J. Rita, M. U. Majithya and S. R. Rayassa, “Design and Development of Microemulsion Drug Delivery System of Acyclovir for Improvement of Oral Bioavailability,” AAPS PharmSciTech, Vol. 7, No. 3, 2006, pp. 1-6.
[68] A. G. Floyd, “Top Ten Considerations in the Development of Parenteral Emulsions,” Pharmaceutical Science and Technology Today, Vol. 2, No. 4, 1999, pp. 134-143. doi:10.1016/S1461-5347(99)00141-8
[69] F. Shakeel, S. Baboota, A. Ahuja, J. Ali, M. S Faisal and S. Shafiq, “Stability Evaluation of Celecoxib Nanoemul- Sion Containing Tween 80,” Thailand Journal of Pharmaceutical Science, Vol. 32, 2008, pp. 4-9.
[70] F. Shakeel, S. Baboota, A. Ahuja, J. Ali and S. Shafiq, “Skin Permeation Mechanism of Aceclofenac Using Novel Nanoemulsion Formulation,” Pharmazie, Vol. 63, No. 8, 2008, pp. 580-584.
[71] S. Baboota, F. Shakeel, A. Ahuja, J. Ali and S. Shafiq, “Design Development and Evaluation of Novel Nanoemulsions Formulations for Transdermal Potential of Celecoxib,” Acta Pharmaceutica, Vol. 8, 2007, pp. 316-332.
[75] J. Cui, B. Yu, W. Zhao, H. Li, H. Lou and G. Zhai, “Enhancement of Oral Absorption of Curcumin by Self-Microemulsifying Drug Delivery Systems,” International Journal of Pharmaceutics, Vol. 371, No. 1-2, 2009, pp. 148-155. doi:10.1016/j.ijpharm.2008.12.009
[76] Y. Tsai, K. Lee, Y. Huang and P. Wu, “In Vitro Permeation and in Vivo Whitening Effect of Topical Hesperetin Microemulsion Delivery System,” International Journal of Pharmaceutics, Vol. 388, No. 1-2, 2010, pp. 257-262. doi:10.1016/j.ijpharm.2009.12.051
[77] J. Xu, et al., “The preparation of Neem Oil Microemulsion (Azadirachta indica) and the Comparison of Acaricidal Time between Neem Oil Microemulsion and Other Formulations in Vitro,” Veterinary Parasitology, Vol. 169, No. 3-4, 2010, pp. 399-403. doi:10.1016/j.vetpar.2010.01.016

comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.